-Reuters
-Reuters
Piper Sandler Maintains Overweight on Dollar Gen, Lowers Price Target to $275
Piper Sandler analyst Peter Keith maintains Dollar Gen (NYSE:DG) with a Overweight and lowers the price target from $288 to $275.
Related Posts
Evolus Not Affected By Recent Korean Court Ruling; Ruling By The Seoul Central District Court Does Not Affect Evolus’ Ability To Have Jeuveau Or Nuceiva Manufactured And Exported By Daewoong Or To Sell The Products In Any Of Its Markets
No Effect on Manufacture, Export, Supply or Sale of Jeuveau® or Nuceiva®
Settlement Agreement with Medytox Provided for Continued Manufacturing and Commercialization for Evolus Regardless of Any
RBC Capital Maintains Outperform on Magnet Forensics, Raises Price Target to C$38
RBC Capital analyst Paul Treiber maintains Magnet Forensics (TSX:MAGT) with a Outperform and raises the price target from C$35 to C$38.
OraSure Wins $41.5M Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention
OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Company has been selected to provide its